Access cutting-edge kidney cancer treatment through this clinical trial at a research site in New Orleans. Study-provided care at no cost to qualified participants.
Access kidney cancer specialists in New Orleans at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney cancer treatment provided free
This is a randomized, Phase 3, double-blind, placebo-controlled study of pazopanib plus abexinostat versus pazopanib plus placebo in patients with locally advanced unresectable or metastatic renal cell carcinoma (RCC).
Sponsor: Xynomic Pharmaceuticals, Inc.
Check if you qualify for this kidney cancer clinical trial in New Orleans, LA
If you're searching for kidney cancer treatment options in New Orleans, LA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Orleans research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.